Abstract

The world’s biggest killer is ischemic heart disease, responsible for 16% of the world’s total deaths. Transient alterations in the hematological and biochemical profile are known to occur of patients admitted with acute ST elevation myocardial infarction. Some of these parameters may help to identify high risk patients with increased likelihood of developing adverse cardiac events. Identifying such high-risk patients help the treating physician to plan more aggressive treatment strategies for these patients resulting in improved clinical outcome

Description